Gene Therapy in Action: Volume #5
In Dr Hauke’s fifth edition of HGT in Action, we spotlight CTLA4 haploinsufficiency, a rare disease profoundly impacting the immune system. Read along as we highlight gene therapy’s application, clinical studies, and provide additional resources.
CONTENT TYPE
Gene Therapy in Action: Volume #4
In "HGT in Action #4", Caitlyn Hauke, PhD, RBP, CBSP(ABSA) discusses the rare genetic blood disorder, Thalassemia. Inside, we highlight gene therapy as a treatment, three current clinical trials, and one FDA-approved gene therapy product.
Thompson Street Capital Partners Invests in Sabai Global
Sabai Global is excited to announce its new partnership with TSCP. Our partnership will propel Sabai Global to new heights of innovation and growth, and we eagerly anticipate our continued and shared successes.
Read more in our press release below, published by Business Wire.
CEO Chris Featured in Parexel xTalk
Watch the official webinar, 'Moving Cell and Gene Therapy Trials into the Community: Challenges and Opportunities', below.
Congratulations to Heidi Page, Shield Consulting's New Director!
A very big congratulations to Heidi Page, MS, RBP for her promotion to Director of Shield Consulting! Thank you for your continued commitment and hard work, we look forward to our continued successes!
We're Attending AAHRPP 2023!
The Castle IRB team is eager to attend this year's annual AAHRPP conference! Read more about the event below.
Congratulations, Melissa Fitzgerald!
Congratulations to Melissa Fitzgerald on her promotion to Operations Manager! We are proud to acknowledge her passion, expertise, and unwavering commitment to our team.
Congratulations on Your Promotion, Jessica Poole!
Congratulations, Jessica Poole, on your promotion to Operations Manager! We greatly appreciate your exceptional expertise and are proud to recognize the invaluable contributions you bring to our operations.
Sabai Global Celebrates Rare Disease Day 2023
The Sabai family is proud to celebrate this year's Rare Disease day, February 28th. Click below for more information:
Overview: Updated NIH Date Management Sharing Policy
Join us in breaking down this up to date NIH policy, effective January 25th.
Gene Therapy in Action: Volume #3
Join us this month in discussing Hunter’s Syndrome (MPS II), an impactful rare disease affecting the metabolism of carbohydrates in the body.
Gene Therapy Seminar Series February 2023
This month, we discussed recent advancements in human gene therapy technologies and their application in addressing sensorineural hearing loss.
Welcome to the Team, Dr. Reeme!
A very warm welcome to Allison Reeme, who has joined our Shield Consulting team as a Project Manager – Biosafety Officer!
Gene Therapy in Action: Volume #2
This month we are exploring Fabry Disease, a rare genetic disease that affects the metabolism of glycosphingolipids.
Gene Therapy in Action: Volume #1
Introducing Gene Therapy in Action, our latest blog-style publication spotlighting rare diseases and cancers. This week we are exploring Amyotrophic Lateral Sclerosis (ALS)
